|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions increases phosphorylation
|
ISO
|
epigallocatechin gallate inhibits the reaction [Imiquimod results in increased phosphorylation of AKT1 protein]
|
CTD |
PMID:24990399 PMID:29402411 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of APEX1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of BCL2 protein
|
CTD |
PMID:20033192 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Blm
|
BLM RecQ like helicase
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of BLM mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
|
|
| G
|
Brca2
|
BRCA2, DNA repair associated
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of BRCA2 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194
|
|
| G
|
Bst2
|
bone marrow stromal cell antigen 2
|
increases expression
|
ISO
|
Imiquimod results in increased expression of BST2 protein
|
CTD |
PMID:31093508 |
|
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
multiple interactions increases expression
|
ISO
|
evodiamine inhibits the reaction [Imiquimod results in increased expression of CALCA mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of CALCA protein] Imiquimod results in increased expression of CALCA mRNA; Imiquimod results in increased expression of CALCA protein
|
CTD |
PMID:38948922 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Casp1
|
caspase 1
|
increases activity multiple interactions
|
ISO
|
Imiquimod results in increased activity of CASP1 protein [Dronabinol inhibits the reaction [Imiquimod results in increased activity of CASP1 protein]] which affects the localization of IL1B protein; Dronabinol inhibits the reaction [Imiquimod results in increased activity of CASP1 protein] [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased cleavage of CASP1 protein; lonidamine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased cleavage of CASP1 protein]
|
CTD |
PMID:31383729 PMID:36577999 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp3
|
caspase 3
|
increases activity increases cleavage
|
ISO
|
imiquimod results in increased activity of CASP3 protein imiquimod results in increased cleavage of CASP3 protein
|
CTD |
PMID:12902443 PMID:20033192 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases secretion
|
ISO
|
Imiquimod results in increased secretion of CCL2 protein
|
CTD |
PMID:34740670 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cd274
|
CD274 molecule
|
increases expression
|
ISO
|
Imiquimod results in increased expression of CD274 protein
|
CTD |
PMID:31093508 |
|
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951
|
|
| G
|
Cd40
|
CD40 molecule
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of CD40 protein LGMN gene mutant form inhibits the reaction [Imiquimod results in increased expression of CD40 protein]
|
CTD |
PMID:22916010 PMID:31093508 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd80
|
Cd80 molecule
|
increases expression
|
ISO
|
Imiquimod results in increased expression of CD80 protein
|
CTD |
PMID:31093508 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
| G
|
Cd86
|
CD86 molecule
|
multiple interactions increases expression
|
ISO
|
[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of CD86 protein; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased expression of CD86 protein]; Tetrachlorodibenzodioxin promotes the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of CD86 protein]
|
CTD |
PMID:21097750 PMID:22916010 PMID:31093508 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Chaf1a
|
chromatin assembly factor 1 subunit A
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of CHAF1A mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868
|
|
| G
|
Chaf1b
|
chromatin assembly factor 1 subunit B
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of CHAF1B mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
|
|
| G
|
Ctsb
|
cathepsin B
|
increases activity
|
ISO
|
Imiquimod results in increased activity of CTSB protein
|
CTD |
PMID:22916010 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsk
|
cathepsin K
|
increases activity
|
ISO
|
Imiquimod results in increased activity of CTSK protein
|
CTD |
PMID:22916010 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Ctsl
|
cathepsin L
|
increases activity
|
ISO
|
Imiquimod results in increased activity of CTSL protein
|
CTD |
PMID:22916010 |
|
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
|
|
| G
|
Ctss
|
cathepsin S
|
increases activity
|
ISO
|
Imiquimod results in increased activity of CTSS protein
|
CTD |
PMID:22916010 |
|
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO
|
[Pam(3)CSK(4) peptide co-treated with Antigens, Bacterial co-treated with Poly I-C co-treated with Lipopolysaccharides co-treated with FSL-1 lipoprotein, synthetic co-treated with imiquimod co-treated with Polyribonucleotides co-treated with ProMune] results in increased expression of CXCL10 protein; Particulate Matter inhibits the reaction [[Pam(3)CSK(4) peptide co-treated with Antigens, Bacterial co-treated with Poly I-C co-treated with Lipopolysaccharides co-treated with FSL-1 lipoprotein, synthetic co-treated with imiquimod co-treated with Polyribonucleotides co-treated with ProMune] results in increased expression of CXCL10 protein]; Vehicle Emissions inhibits the reaction [[Pam(3)CSK(4) peptide co-treated with Antigens, Bacterial co-treated with Poly I-C co-treated with Lipopolysaccharides co-treated with FSL-1 lipoprotein, synthetic co-treated with imiquimod co-treated with Polyribonucleotides co-treated with ProMune] results in increased expression of CXCL10 protein]
|
CTD |
PMID:28655636 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
increases secretion increases expression multiple interactions
|
ISO
|
Imiquimod results in increased secretion of CXCL1 protein Imiquimod results in increased expression of CXCL1 mRNA hispidulin inhibits the reaction [Imiquimod results in increased expression of CXCL1 mRNA]
|
CTD |
PMID:22916010 PMID:32679548 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases metabolic processing increases chemical synthesis multiple interactions affects metabolic processing
|
ISO
|
CYP1A1 protein results in increased metabolism of Imiquimod CYP1A1 protein results in increased chemical synthesis of Imiquimod metabolite [CYP1A1 protein results in increased metabolism of Imiquimod] which results in increased chemical synthesis of Imiquimod metabolite CYP1A1 protein affects the metabolism of Imiquimod CYP1A1 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod]
|
CTD |
PMID:31111189 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions increases metabolic processing increases chemical synthesis affects metabolic processing
|
ISO
|
[CYP1A2 protein results in increased metabolism of Imiquimod] which results in increased chemical synthesis of Imiquimod metabolite CYP1A2 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod] CYP1A2 protein results in increased chemical synthesis of Imiquimod metabolite CYP1A2 protein affects the metabolism of Imiquimod
|
CTD |
PMID:31111189 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
increases metabolic processing
|
ISO
|
CYP2C19 protein results in increased metabolism of Imiquimod
|
CTD |
PMID:31111189 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
increases metabolic processing
|
ISO
|
CYP2D6 protein results in increased metabolism of Imiquimod
|
CTD |
PMID:31111189 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Dnm3
|
dynamin 3
|
increases expression
|
ISO
|
Imiquimod results in increased expression of DNM3 mRNA
|
CTD |
PMID:38760990 |
|
NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350
|
|
| G
|
Ercc2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of ERCC2 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102
|
|
| G
|
Ercc5
|
ERCC excision repair 5, endonuclease
|
increases expression
|
ISO
|
imiquimod results in increased expression of ERCC5 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084
|
|
| G
|
Fancl
|
FA complementation group L
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of FANCL mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297
|
|
| G
|
Fbh1
|
F-box DNA helicase 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of FBH1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr17:71,659,351...71,697,431
Ensembl chr17:71,659,249...71,697,432
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of FGF2
|
CTD |
PMID:16368197 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Gsdmd
|
gasdermin D
|
multiple interactions
|
ISO
|
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased cleavage of GSDMD protein; lonidamine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased cleavage of GSDMD protein]
|
CTD |
PMID:36577999 |
|
NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722
|
|
| G
|
Gtf2h3
|
general transcription factor IIH subunit 3
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of GTF2H3 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr12:37,669,995...37,687,505
Ensembl chr12:37,669,997...37,686,466
|
|
| G
|
Gtf2h4
|
general transcription factor 2H subunit 4
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of GTF2H4 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr20:3,076,110...3,081,805
Ensembl chr20:3,076,088...3,081,760
|
|
| G
|
Gzmb
|
granzyme B
|
multiple interactions
|
ISO
|
Imiquimod results in increased expression of and results in increased secretion of GZMB protein
|
CTD |
PMID:31093508 |
|
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469
|
|
| G
|
H2ax
|
H2A.X variant histone
|
decreases expression
|
ISO
|
Imiquimod results in decreased expression of H2AX mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO
|
[imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ICAM1 protein; Tetrachlorodibenzodioxin promotes the reaction [[imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ICAM1 protein]
|
CTD |
PMID:21097750 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions
|
ISO
|
[Hydroxychloroquine co-treated with Imiquimod] results in increased secretion of IL10 protein
|
CTD |
PMID:31082466 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il11
|
interleukin 11
|
multiple interactions decreases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL11 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
| G
|
Il11ra1
|
interleukin 11 receptor subunit alpha 1
|
multiple interactions decreases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL11RA1 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:61,727,931...61,737,264
|
|
| G
|
Il12a
|
interleukin 12A
|
multiple interactions increases secretion
|
ISO
|
[imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]; Tetrachlorodibenzodioxin inhibits the reaction [[imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]] Imiquimod results in increased secretion of IL12A protein
|
CTD |
PMID:21097750 PMID:31093508 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
| G
|
Il12b
|
interleukin 12B
|
multiple interactions increases expression increases secretion
|
ISO
|
[Imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL12B mRNA]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased secretion of IL12B protein]; Tetrachlorodibenzodioxin inhibits the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]]
|
CTD |
PMID:21097750 PMID:22916010 PMID:31054998 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il13ra1
|
interleukin 13 receptor subunit alpha 1
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL13RA1 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461
|
|
| G
|
Il13ra2
|
interleukin 13 receptor subunit alpha 2
|
increases expression
|
ISO
|
Imiquimod results in increased expression of IL13RA2 mRNA
|
CTD |
PMID:31054998 |
|
NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455
|
|
| G
|
Il17a
|
interleukin 17A
|
multiple interactions increases secretion increases expression
|
ISO
|
(+)-JQ1 compound inhibits the reaction [Imiquimod results in increased expression of IL17A mRNA]; (+)-JQ1 compound inhibits the reaction [Imiquimod results in increased secretion of IL17A protein]; Chloroquine inhibits the reaction [Imiquimod results in increased expression of IL17A protein]; evodiamine inhibits the reaction [Imiquimod results in increased expression of IL17A protein]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL17A mRNA]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL17A protein]; hispidulin inhibits the reaction [Imiquimod results in increased expression of IL17A mRNA]; Resveratrol inhibits the reaction [Imiquimod results in increased expression of IL17A mRNA]; SR 1078 inhibits the reaction [(+)-JQ1 compound inhibits the reaction [Imiquimod results in increased expression of IL17A mRNA]]; SR 1078 inhibits the reaction [(+)-JQ1 compound inhibits the reaction [Imiquimod results in increased secretion of IL17A protein]] imiquimod results in increased secretion of IL17A protein Imiquimod results in increased expression of IL17A mRNA; Imiquimod results in increased expression of IL17A protein
|
CTD |
PMID:25965695 PMID:26149470 PMID:31054998 PMID:32679548 PMID:36002070 PMID:38948922 More...
|
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il17b
|
interleukin 17B
|
decreases expression multiple interactions
|
ISO
|
Imiquimod results in decreased expression of IL17B mRNA ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL17B mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr18:57,411,532...57,415,903
Ensembl chr18:57,411,532...57,415,903
|
|
| G
|
Il17rb
|
interleukin 17 receptor B
|
decreases expression multiple interactions
|
ISO
|
Imiquimod results in decreased expression of IL17RB mRNA ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL17RB mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694
|
|
| G
|
Il18
|
interleukin 18
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL18 mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL18 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18bp
|
interleukin 18 binding protein
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL18BP mRNA hispidulin inhibits the reaction [Imiquimod results in increased expression of IL18BP mRNA]
|
CTD |
PMID:32679548 |
|
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955
|
|
| G
|
Il18rap
|
interleukin 18 receptor accessory protein
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL18RAP mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583
|
|
| G
|
Il19
|
interleukin 19
|
increases expression multiple interactions
|
ISO
|
imiquimod results in increased expression of IL19 mRNA resveratrol inhibits the reaction [imiquimod results in increased expression of IL19 mRNA]
|
CTD |
PMID:25965695 |
|
NCBI chr13:44,949,989...44,958,714
Ensembl chr13:44,949,989...44,958,714
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL1A mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases secretion multiple interactions increases expression
|
ISO
|
Imiquimod results in increased secretion of IL1B protein [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with Imiquimod] results in increased secretion of IL1B protein; Chloroquine inhibits the reaction [Imiquimod results in increased expression of IL1B protein]; Chlorquinaldol inhibits the reaction [[Lipopolysaccharides co-treated with Imiquimod] results in increased secretion of IL1B protein]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL1B mRNA]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL1B protein]; hispidulin inhibits the reaction [Imiquimod results in increased expression of IL1B mRNA]; lonidamine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Imiquimod] results in increased secretion of IL1B protein] Imiquimod results in increased expression of IL1B mRNA; Imiquimod results in increased expression of IL1B protein [Dronabinol inhibits the reaction [Imiquimod results in increased activity of CASP1 protein]] which affects the localization of IL1B protein; Cannabidiol inhibits the reaction [Imiquimod results in increased secretion of IL1B protein]; Dronabinol inhibits the reaction [Imiquimod results in increased expression of IL1B mRNA]; Dronabinol inhibits the reaction [Imiquimod results in increased secretion of IL1B protein]; JHW 015 inhibits the reaction [Imiquimod results in increased secretion of IL1B protein]
|
CTD |
PMID:18403674 PMID:31054998 PMID:31082466 PMID:31383729 PMID:32679548 PMID:34740670 PMID:36002070 PMID:36577999 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1f10
|
interleukin 1 family member 10
|
decreases expression multiple interactions
|
ISO
|
Imiquimod results in decreased expression of IL1F10 mRNA ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL1F10 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:27,470,798...27,473,726
Ensembl chr 3:27,470,798...27,473,726
|
|
| G
|
Il1rap
|
interleukin 1 receptor accessory protein
|
increases expression
|
ISO
|
Imiquimod results in increased expression of IL1RAP mRNA
|
CTD |
PMID:31054998 |
|
NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342
|
|
| G
|
Il2
|
interleukin 2
|
increases secretion
|
ISO
|
Imiquimod results in increased secretion of IL2 protein
|
CTD |
PMID:34740670 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il20
|
interleukin 20
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL20 mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL20 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr13:44,933,249...44,936,893
Ensembl chr13:44,933,249...44,936,893
|
|
| G
|
Il20rb
|
interleukin 20 receptor subunit beta
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL20RB mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL20RB mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363
|
|
| G
|
Il22ra1
|
interleukin 22 receptor subunit alpha 1
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL22RA1 mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL22RA1 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:153,245,002...153,271,683
|
|
| G
|
Il23a
|
interleukin 23 subunit alpha
|
increases secretion increases expression multiple interactions
|
ISO
|
imiquimod results in increased secretion of IL23A protein Imiquimod results in increased expression of IL23A mRNA; Imiquimod results in increased expression of IL23A protein evodiamine inhibits the reaction [Imiquimod results in increased expression of IL23A protein]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL23A mRNA]; ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL23A protein]
|
CTD |
PMID:25965695 PMID:26149470 PMID:31054998 PMID:38948922 |
|
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
|
|
| G
|
Il27
|
interleukin 27
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL27 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 1:190,603,684...190,609,292
Ensembl chr 1:190,603,522...190,609,258
|
|
| G
|
Il33
|
interleukin 33
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL33 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il36a
|
interleukin 36, alpha
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL36A mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL36A mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:27,395,146...27,399,695
Ensembl chr 3:27,395,146...27,399,695
|
|
| G
|
Il36b
|
interleukin 36, beta
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL36B mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL36B mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:27,422,980...27,521,344
Ensembl chr 3:27,423,171...27,428,678
|
|
| G
|
Il36g
|
interleukin 36, gamma
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL36G mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:27,346,675...27,352,839
Ensembl chr 3:27,346,670...27,352,834
|
|
| G
|
Il36rn
|
interleukin 36 receptor antagonist
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL36RN mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:27,442,709...27,449,306
|
|
| G
|
Il4
|
interleukin 4
|
increases secretion
|
ISO
|
Imiquimod results in increased secretion of IL4 protein
|
CTD |
PMID:34740670 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases secretion increases expression
|
ISO
|
[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased secretion of IL6 protein; concanamycin B inhibits the reaction [Imiquimod results in increased secretion of IL6 protein]; hispidulin inhibits the reaction [Imiquimod results in increased expression of IL6 mRNA]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased secretion of IL6 protein]; MV026630 inhibits the reaction [Imiquimod results in increased secretion of IL6 protein] [Hydroxychloroquine co-treated with Imiquimod] results in increased secretion of IL6 protein; Cannabidiol promotes the reaction [Imiquimod results in increased secretion of IL6 protein]
|
CTD |
PMID:21097750 PMID:22916010 PMID:31082466 PMID:31093508 PMID:31383729 PMID:32679548 PMID:34740670 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il7
|
interleukin 7
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IL7 mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL7 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 2:96,142,523...96,186,282
Ensembl chr 2:96,142,092...96,187,389
|
|
| G
|
Il7r
|
interleukin 7 receptor
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IL7R mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
|
|
| G
|
Il9r
|
interleukin 9 receptor
|
decreases expression multiple interactions
|
ISO
|
Imiquimod results in decreased expression of IL9R mRNA ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL9R mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr10:15,936,156...15,947,613
Ensembl chr10:15,936,156...15,947,613
|
|
| G
|
Irak2
|
interleukin-1 receptor-associated kinase 2
|
multiple interactions increases expression
|
ISO
|
ferulic acid inhibits the reaction [Imiquimod results in increased expression of IRAK2 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
|
|
| G
|
Irak3
|
interleukin-1 receptor-associated kinase 3
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of IRAK3 mRNA ferulic acid inhibits the reaction [Imiquimod results in increased expression of IRAK3 mRNA]
|
CTD |
PMID:31054998 |
|
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706
|
|
| G
|
Itgax
|
integrin subunit alpha X
|
multiple interactions
|
ISO
|
[imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ITGAX protein; Tetrachlorodibenzodioxin inhibits the reaction [[imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ITGAX protein]
|
CTD |
PMID:21097750 |
|
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151
|
|
| G
|
Kif22
|
kinesin family member 22
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of KIF22 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878
|
|
| G
|
Lgmn
|
legumain
|
increases activity multiple interactions
|
ISO
|
Imiquimod results in increased activity of LGMN protein LGMN gene mutant form inhibits the reaction [Imiquimod results in increased cleavage of TLR7 protein]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased expression of CD40 protein]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased expression of CD86 protein]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased secretion of IL12B protein]; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased secretion of IL6 protein]
|
CTD |
PMID:22916010 |
|
NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328
|
|
| G
|
Lig1
|
DNA ligase 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of LIG1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
|
|
| G
|
Lrch4
|
leucine rich repeats and calponin homology domain containing 4
|
multiple interactions
|
ISO
|
LRCH4 protein promotes the reaction [Imiquimod results in increased expression of TNF protein]
|
CTD |
PMID:30523158 |
|
NCBI chr12:24,694,364...24,709,354
Ensembl chr12:24,694,370...24,706,412
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases phosphorylation
|
ISO
|
imiquimod results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:20033192 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation
|
ISO
|
imiquimod results in decreased phosphorylation of MAPK3 protein
|
CTD |
PMID:20033192 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mlh1
|
mutL homolog 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of MLH1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases activity
|
ISO
|
imiquimod results in decreased activity of MMP9 protein
|
CTD |
PMID:14708627 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpg
|
N-methylpurine-DNA glycosylase
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of MPG mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052
|
|
| G
|
Mpo
|
myeloperoxidase
|
increases activity multiple interactions increases expression
|
ISO
|
imiquimod results in increased activity of MPO protein (+)-JQ1 compound inhibits the reaction [Imiquimod results in increased activity of MPO protein]; hispidulin inhibits the reaction [Imiquimod results in increased expression of MPO protein]; SR 1078 inhibits the reaction [(+)-JQ1 compound inhibits the reaction [Imiquimod results in increased activity of MPO protein]]
|
CTD |
PMID:26149470 PMID:32679548 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mre11
|
MRE11 homolog, double strand break repair nuclease
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of MRE11A mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:19,913,772...19,961,904
|
|
| G
|
Msh2
|
mutS homolog 2
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of MSH2 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503
|
|
| G
|
Ngf
|
nerve growth factor
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of NGF mRNA; Imiquimod results in increased expression of NGF protein evodiamine inhibits the reaction [Imiquimod results in increased expression of NGF mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of NGF protein]
|
CTD |
PMID:38948922 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Nudt1
|
nudix hydrolase 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of NUDT1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:19,416,411...19,424,158
|
|
| G
|
Pck1
|
phosphoenolpyruvate carboxykinase 1
|
multiple interactions
|
ISO
|
[resveratrol co-treated with imiquimod] results in increased expression of PCK1 mRNA
|
CTD |
PMID:25965695 |
|
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of PCNA protein Chloroquine inhibits the reaction [Imiquimod results in increased expression of PCNA protein]
|
CTD |
PMID:36002070 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pmel
|
premelanosome protein
|
increases expression
|
ISO
|
Imiquimod results in increased expression of PMEL protein
|
CTD |
PMID:38760990 |
|
NCBI chr 7:1,721,948...1,733,248
Ensembl chr 7:1,722,297...1,733,248
|
|
| G
|
Pms2
|
PMS1 homolog 2, mismatch repair system component
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of PMS2 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr12:15,790,478...15,814,790
Ensembl chr12:15,790,478...15,815,248
|
|
| G
|
Pole
|
DNA polymerase epsilon, catalytic subunit
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of POLE mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662
|
|
| G
|
Poll
|
DNA polymerase lambda
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of POLL mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:254,349,229...254,357,689
Ensembl chr 1:254,349,231...254,358,020
|
|
| G
|
Pomc
|
proopiomelanocortin
|
increases expression
|
ISO
|
Imiquimod results in increased expression of POMC protein
|
CTD |
PMID:38760990 |
|
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
|
|
| G
|
Ppp1r3c
|
protein phosphatase 1, regulatory subunit 3C
|
multiple interactions
|
ISO
|
[resveratrol co-treated with imiquimod] results in decreased expression of PPP1R3C mRNA
|
CTD |
PMID:25965695 |
|
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
|
|
| G
|
Prkch
|
protein kinase C, eta
|
increases expression
|
ISO
|
Imiquimod results in increased expression of PRKCH mRNA
|
CTD |
PMID:38760990 |
|
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477
|
|
| G
|
Rad51ap1
|
RAD51 associated protein 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of RAD51AP1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680
|
|
| G
|
Rad51d
|
RAD51 paralog D
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of RAD51D mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr10:68,303,350...68,322,002
Ensembl chr10:68,238,273...68,321,902
|
|
| G
|
Rad54l
|
RAD54 like
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of RAD54L mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:134,811,532...134,841,425
|
|
| G
|
RFFL
|
ring finger and FYVE like domain containing E3 ubiquitin protein ligase
|
decreases expression
|
ISO
|
Imiquimod results in decreased expression of RAD51D mRNA
|
CTD |
PMID:21878529 |
|
|
|
| G
|
Rorc
|
RAR-related orphan receptor C
|
increases expression multiple interactions
|
ISO
|
imiquimod results in increased expression of RORC mRNA; imiquimod results in increased expression of RORC protein (+)-JQ1 compound inhibits the reaction [imiquimod results in increased expression of RORC mRNA]; (+)-JQ1 compound inhibits the reaction [imiquimod results in increased expression of RORC protein]
|
CTD |
PMID:26149470 |
|
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
|
|
| G
|
Ruvbl2
|
RuvB-like AAA ATPase 2
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of RUVBL2 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 1:105,038,487...105,051,851
Ensembl chr 1:105,038,174...105,051,720
|
|
| G
|
S100a1
|
S100 calcium binding protein A1
|
increases expression
|
ISO
|
Imiquimod results in increased expression of S100A1 protein
|
CTD |
PMID:38760990 |
|
NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:178,291,503...178,296,346
|
|
| G
|
Slc47a1
|
solute carrier family 47 member 1
|
multiple interactions
|
ISO
|
imiquimod inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:22419765 |
|
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,533,583...46,587,096
|
|
| G
|
Slc47a2
|
solute carrier family 47 member 2
|
multiple interactions
|
ISO
|
imiquimod inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]
|
CTD |
PMID:22419765 |
|
NCBI chr10:46,490,262...46,532,954
Ensembl chr10:46,489,831...46,533,425
|
|
| G
|
Ssrp1
|
structure specific recognition protein 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of SSRP1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 3:90,531,024...90,541,132
Ensembl chr 3:90,530,829...90,541,129
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression
|
ISO
|
imiquimod results in increased expression of STAT3 mRNA
|
CTD |
PMID:26149470 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tac1
|
tachykinin, precursor 1
|
multiple interactions increases expression
|
ISO
|
evodiamine inhibits the reaction [Imiquimod results in increased expression of TAC1 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TAC1 protein] Imiquimod results in increased expression of TAC1 mRNA; Imiquimod results in increased expression of TAC1 protein
|
CTD |
PMID:38948922 |
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases secretion
|
ISO
|
Imiquimod results in increased secretion of TGFB1 protein
|
CTD |
PMID:34740670 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
ISO
|
imiquimod results in increased expression of TIMP1 protein
|
CTD |
PMID:14708627 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tlr7
|
toll-like receptor 7
|
multiple interactions affects binding increases cleavage
|
ISO
|
[Imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]; [Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of CD86 protein; [Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ICAM1 protein; [Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ITGAX protein; [Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased secretion of IL6 protein; LGMN gene mutant form inhibits the reaction [Imiquimod results in increased cleavage of TLR7 protein]; Tetrachlorodibenzodioxin inhibits the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] results in increased secretion of [IL12A protein binds to IL12B protein]]; Tetrachlorodibenzodioxin inhibits the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ITGAX protein]; Tetrachlorodibenzodioxin promotes the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of CD86 protein]; Tetrachlorodibenzodioxin promotes the reaction [[Imiquimod binds to and results in increased activity of TLR7 protein] which results in increased expression of ICAM1 protein] Imiquimod binds to TLR7 protein
|
CTD |
PMID:21097750 PMID:22916010 PMID:31093508 |
|
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:30,644,355...30,672,151
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression increases secretion decreases expression
|
ISO
|
CGP 57380 inhibits the reaction [Imiquimod results in increased expression of TNF protein]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TNF protein]; hispidulin inhibits the reaction [Imiquimod results in increased expression of TNF protein]; LRCH4 protein promotes the reaction [Imiquimod results in increased expression of TNF protein] Imiquimod results in increased expression of TNF mRNA; Imiquimod results in increased expression of TNF protein Imiquimod results in increased secretion of TNF protein Cannabidiol promotes the reaction [Imiquimod results in increased secretion of TNF protein] Imiquimod results in decreased expression of TNF protein
|
CTD |
PMID:18032482 PMID:25965695 PMID:26149470 PMID:30523158 PMID:31093508 PMID:32679548 PMID:34740670 PMID:38760990 PMID:38948922 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Trex1
|
three prime repair exonuclease 1
|
increases expression
|
ISO
|
imiquimod results in increased expression of TREX1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083
|
|
| G
|
Trim63
|
tripartite motif containing 63
|
multiple interactions
|
ISO
|
[resveratrol co-treated with imiquimod] results in increased expression of TRIM63 mRNA
|
CTD |
PMID:25965695 |
|
NCBI chr 5:151,817,209...151,831,026
Ensembl chr 5:151,817,225...151,831,058
|
|
| G
|
Trpv1
|
transient receptor potential cation channel, subfamily V, member 1
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of TRPV1 mRNA; Imiquimod results in increased expression of TRPV1 protein evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV1 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV1 protein]
|
CTD |
PMID:38948922 |
|
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021
|
|
| G
|
Trpv3
|
transient receptor potential cation channel, subfamily V, member 3
|
multiple interactions increases expression
|
ISO
|
evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV3 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV3 protein] Imiquimod results in increased expression of TRPV3 mRNA; Imiquimod results in increased expression of TRPV3 protein
|
CTD |
PMID:38948922 |
|
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800
|
|
| G
|
Trpv4
|
transient receptor potential cation channel, subfamily V, member 4
|
increases expression multiple interactions
|
ISO
|
Imiquimod results in increased expression of TRPV4 mRNA; Imiquimod results in increased expression of TRPV4 protein evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV4 mRNA]; evodiamine inhibits the reaction [Imiquimod results in increased expression of TRPV4 protein]
|
CTD |
PMID:38948922 |
|
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143
|
|
| G
|
Tyr
|
tyrosinase
|
multiple interactions increases activity
|
ISO
|
Imiquimod results in increased expression of and results in increased activity of TYR protein Imiquimod results in increased activity of TYR protein
|
CTD |
PMID:38760990 |
|
NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:150,527,687...150,622,857
|
|
| G
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of UHRF1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792
|
|
| G
|
Wrnip1
|
WRN helicase interacting protein 1
|
decreases expression
|
ISO
|
imiquimod results in decreased expression of WRNIP1 mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr17:31,830,159...31,850,408
Ensembl chr17:31,830,160...31,850,408
|
|
| G
|
Xpc
|
XPC complex subunit, DNA damage recognition and repair factor
|
increases expression
|
ISO
|
imiquimod results in increased expression of XPC mRNA
|
CTD |
PMID:21878529 |
|
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
Tilorone results in decreased activity of ACHE protein
|
CTD |
PMID:33400519 PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|